Atar D, Munkhaugen J, Prescott EIB, Jernberg T, Ibáñez B(2026) The use of β-blockers after myocardial infarction: no doubts remain Nat Rev Cardiol(in press) DOI 10.1038/s41569-026-01252-4, PubMed 41555043
Rubboli A, Atar D(2025) Subclinical Atherosclerotic Coronary Artery Disease: Considerations on a New Modifier of Cardiovascular Risk Cardiology, 1-2(in press) DOI 10.1159/000549952, PubMed 41490400
Jortveit J, Munkhaugen J, Kaldal A, Halvorsen S(2025) Secondary prevention in myocardial infarction patients with known coronary artery disease Tidsskr Nor Laegeforen, 145(15) DOI 10.4045/tidsskr.25.0186, PubMed 41410966